Amicus Therapeutics (FOLD)

4.91 -0.08  -1.60%  May 29, 11:50AM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

Amicus Therapeutics Performance

Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.

5 Year Total Returns Performance

Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)

Returns -65.97%
Total Returns -65.97%

1 Year Total Returns Performance Comparison

Here are Amicus Therapeutics's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.

  • FOLD Total Returns
  • ^SPXTR Total Returns
  • ACOR Total Returns
  • OMER Total Returns
1 month total returns YTD total returns 1 year total returns* 3 year total returns
FOLD -6.83% 42.73% -36.23% -26.05%
^SPXTR -5.89% 5.70% 1.18% 54.61%
ACOR -11.39% -6.00% -32.26% -9.05%
OMER 15.49% 156.7% 123.8% 1.40%

* May differ from chart if one year ago today was not a trading day. Table uses the previous trading day as a base while chart uses the next trading day.

Fundamental Performance

Price vs Earnings

In the long run, the price and earnings of a company are correlated. If the two metrics are diverging, there should be a good reason why. Divergence without reason can signal danger or opportunity.

Price -54.28%
Earnings Per Share TTM -118.4%

Earnings Yield vs Dividend Yield

Yields show how much you are getting for the price you pay. For example, an earnings yield of 8% means that for every dollar you pay, you get 8 cents worth of current earnings. Take these numbers into account when buying to see if you are over-paying or getting a good deal.

Earnings Yield -25.25%
Dividend Yield 0.00%

Revenue and Earnings Growth

Revenues show how much the company is selling to customers, while net income is what remains for shareholders after the company pays its expenses. Revenue growth often persists over time, but net income is more fickle. Watch closely to see if revenue and income grow at similar rates.

Revenues TTM 23.24M
Net Income TTM -44.20M

Efficent Use of Assets

Profit margins show what percentage of every dollar of sales turns into earnings. Asset Uitlization shows how many dollars of sales a company gets for each dollar that the company invests in assets. Multiplying the two numbers together gives you Return on Assets which tells you approximately how efficiently the company invests money to earn more money.

Profit Margin -169.0%
Asset Utilization 0.2202

Reinvestment Strategy

Return on Invested Capital (ROIC) tells you how much income a company earned after investing $1 in its business. The Payout Ratio tells what percentage of the company's income it pays to shareholders instead of reinvesting in its own growth. Watch out for companies that pay out very little when their ROIC is low.

5 Year Average ROIC -0.6742
5 Year Average Payout Ratio 0.00

You may also be interested in these FOLD related companies

Get Performance for
Display in Live Stream: Done
Options

FOLD News

$FOLD http://stks.co/40of
about 2 hours ago by Engi
10 biotech securities will be added to the Nasdaq biotech index on May 21: $CERS $CLDX $FOLD $INFI $JAZZ $OMER $OREX $PCRX $RPTP $TSRX
about 14 days ago by abubnic
Listen to $FOLD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3mFn
about 19 days ago by earningscast
$FOLD http://stks.co/3Tqh
about 35 days ago by Engi
$FOLD http://stks.co/3Lqx Long setup. Bullish engulfing. 200MA support.
about 44 days ago by VexTrades
$FOLD--Some huge insider buys just came through at 5.70. Do your own research. This looks like a stock offering, but insiders are buying.
about 81 days ago by MicroInsider
$FOLD forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/2hZy
about 83 days ago by RecogniaEvents
$ECTE i see great potential in this one. A skin glucose monitor with no sticks!! Also long $FOLD for a long term play...
about 87 days ago by Stuckinstock
$FOLD Announces Proposed Public Offering of Common Stock; No Amount Given
about 89 days ago by Benzinga
Listen to $FOLD Q4 2011 earnings call (EPS -0.25 vs est -0.37) - live at 05:00 PM, ondemand after - http://stks.co/2Nmy
about 106 days ago by earningscast
$fold,,double bottom 6.93
about 106 days ago by teevee
10:50EST $FOLD Up 8% for the day. Reporting Earnings Today. http://stks.co/2NKe #tradeideas #stocks #investing #earnings
about 106 days ago by TradeIdeas1
$FOLD Presents Preclinical Studies for Gaucher Disease; AVI BioPharma Results From Phase I Clinical Trial. http://stks.co/2LHx
about 109 days ago by abubnic
$FOLD hod on deck
about 133 days ago by tradueruski
$FOLD hod pop
about 133 days ago by tradueruski
$FOLD filed latest Quarterly Report http://stks.co/vVr
about 209 days ago by MarketBrief
$FOLD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/nqC
about 216 days ago by MarketBrief
$FOLD http://chart.ly/o5dekj2 long setup
about 274 days ago by stt2318
$FOLD $6.01 Crowley John F director officer (Executive Chairman) P 20,000 @ $6.04 amnt $120,800 proc'd ($600) 6/17/2011
about 343 days ago by canarionyc
$FOLD $7.56 Valenzano Ken officer (VP, Pharmacology & Biology) S 2,250 @ $7.50 amnt $16,875 proc'd ($135) 5/24/2011
about 370 days ago by canarionyc
$FOLD $30m shelf, max px $4.33
about 504 days ago by canarionyc
Register for BioNJ's annual meeting held 1/27/11, featured speaker J. Crowley, Amicus $FOLD CEO. Register at http://bit.ly/hxEerO #BioNJADM
about 515 days ago by MDBpartners
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/gvoEjM
about 516 days ago by Tieler
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/hLiIKn
about 516 days ago by Tieler
Hey. How about my $FOLD call last week? It's going higher. If not now, for the January Effect
about 890 days ago by TheNewHouse
$FOLD should be on all January Effect players lists. Tax loss selling of the previous year's IPOs often rebound in the new year.
about 893 days ago by TheNewHouse
NASDAQ 3 biggest decliners: $FOLD -34.59%, $FPBI -30.86%, $SNFCA -22.11%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 966 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.44%, $FOLD -34.59%, $FPBI -30.86%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 966 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.44%, $FOLD -34.59%, $FPBI -30.86%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 967 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.71%, $FOLD -33.29%, $FPBI -23.44%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 967 days ago by datajunkies
Yup, $FOLD failed PII Gaucher study. Good news for $PLX & $GENZ (assuming $GENZ ever gets thteir plan opened).
about 970 days ago by delete
Uh oh two halts in biotechs $FOLD and $SCLN. Friday night AH halt is usually not a good sign.
about 970 days ago by delete

Recent Quotes

Symbol Price Chg Chg % Market Cap
FOLD 4.91 -0.08 -1.60% 222.80M
FOH 0.37 +0.00 +0.00% 14.40M
FOF 12.20 +0.11 +0.91%
FOE 4.62 +0.04 +0.87% 396.49M
FNSR 15.09 +0.50 +3.43% 1.325B
FLY 12.35 +0.03 +0.24% 316.01M
FLXS 20.04 +0.05 +0.25% 135.13M
FLT 38.37 -0.09 -0.23% 3.181B
FLR 50.44 +0.73 +1.48% 8.422B
FLOW 3.02 -0.05 -1.63% 146.93M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close